Taken together, DYRK2, as a tumor suppressor, may inhibit metastasis by inducing E-cadherin expression, suppressing S100A4, EMA, and N-cadherin expression, and promoting autophagy by increasing Beclin1 and LC3 expression (Figure 3). Here, DYRK2 is linked to neoplasm.